Type 2 diabetes (T2DM) is a progressive disease characterized by insulin resistance (IR) and beta cell dysfunction. At diagnosis, 50% of beta cells are already lost. This continues as the disease progresses [1-2]. Preservation of residual beta cells is an important target [3]. Usually, T2DM treatment starts with lifestyle improvements,